Research Article
PEGylated Protamine Letrozole Nanoparticles: A Promising Strategy to Combat Human Breast Cancer via MCF-7 Cell Lines
Table 1
Particle size and potential of formulations (F1-F4).
| | Formulation code | PPC | LTZ | TPP | Polydispersity index | Particle size (nm) | Zeta potential |
| | F1 | 30 mg | 5 mg | 0.4% | 0.114 | 258 | 7.4 mV | | F2 | 30 mg | 10 mg | 0.4% | 0.234 | 276 | 8.11 mV | | F3 | 30 mg | 15 mg | 0.4% | 0.45 | 340 | 10.2 mV | | F4 | 30 mg | 20 mg | 0.4% | 0.5 | 388 | 11.2mv |
|
|